Form 4 for OCUL OCULAR THERAPEUTIX, INC
Accepted 2025-02-13 00:00:00 ET · period of report 2025-02-11 · accession 0001104659-25-013156 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2025-02-13 | 2025-02-11 | OCUL | Dugel Pravin | See Remarks, Dir | A - Grant | $0.00 | +2.75M | 2.04M | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-02-11 | A | A | 1,500,000 | $0.00 | 3,541,793 | D | — | — | (F2) On the Grant Date, the reporting person was granted performance stock units ("PSUs") under the 2021 Plan and in accordance with a PSU award agreement (the "PSU Award Agreement"). (F3) Each PSU represents a right to receive one share of the Corporation's common stock. Pursuant to the PSU Award Agreement, the shares underlying the PSUs can be earned during the five-year period beginning on the Grant Date in four equal tranches based on the achievement of share price hurdles if the Company's consecutive 60-day closing share price average meets or exceeds $15.00, $20.00, $25.00, and $30.00 per share (each, a "Share Price Hurdle"). Shares underlying the PSUs that are earned shall vest on the later of (i) the achievement of the applicable Share Price Hurdle or (ii) the three-year anniversary of the Grant Date, in each case subject to the reporting person's continued service to the Corporation. The PSUs are subject to earlier vesting upon certain qualifying termination events pursuant to the PSU Award Agreement. |
| 2 | Common | Common Stock | 2025-02-11 | A | A | 1,250,000 | $0.00 | 2,041,793 | D | — | — | (F1) On February 11, 2025 (the "Grant Date"), the reporting person was granted restricted stock units ("RSUs") under the 2021 Stock Incentive Plan, as amended (the "2021 Plan"), of Ocular Therapeutix, Inc. (the "Corporation"). Each RSU represents a right to receive one share of the Corporation's common stock. Subject to the reporting person's continued service to the Corporation, the RSUs will vest over three years, with 1/3 of the shares underlying the RSUs vesting on the one-year anniversary of the Grant Date and an additional 1/3 of the shares underlying the RSUs vesting at the end of each successive one-year period thereafter. |